Global AAV Gene Therapy Drugs Supply, Demand and Key Producers, 2024-2030

Page: 99

Published Date: 22 Nov 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global AAV Gene Therapy Drugs market size is expected to reach $ 8306 million by 2030, rising at a market growth of 25.7% CAGR during the forecast period (2024-2030).

AAV gene therapy drugs are a type of biological therapeutic that utilizes adeno - associated virus (AAV) as a vector to deliver therapeutic genes into a patient's cells for the purpose of treating diseases. AAV is a small, non - enveloped, single - stranded DNA virus. It has several characteristics that make it an attractive vector for gene therapy. The virus has a relatively simple structure consisting of a protein capsid that encloses its genetic material.

This report studies the global AAV Gene Therapy Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for AAV Gene Therapy Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of AAV Gene Therapy Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global AAV Gene Therapy Drugs total market, 2019-2030, (USD Million)
Global AAV Gene Therapy Drugs total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: AAV Gene Therapy Drugs total market, key domestic companies, and share, (USD Million)
Global AAV Gene Therapy Drugs revenue by player, revenue and market share 2019-2024, (USD Million)
Global AAV Gene Therapy Drugs total market by Type, CAGR, 2019-2030, (USD Million)
Global AAV Gene Therapy Drugs total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global AAV Gene Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Avexis/Novartis (Zolgensma), Sarepta Therapeutics (Elevidys), Spark/Roche (Luxturna), PTC Therapeutics (Upstaza), BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), Pfizer, Beijing Innovikang (Pipeline), Suzhou NoJieBeig (Pipeline), Belief BioMed (Pipeline), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AAV Gene Therapy Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global AAV Gene Therapy Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global AAV Gene Therapy Drugs Market, Segmentation by Type
    scAAV9 Vector
    AVV2 Vector
    AVV5 Vector
    AAVrh74 Vector

Global AAV Gene Therapy Drugs Market, Segmentation by Application:
    Spinal Muscular Atrophy (SMA)
    Ophthalmic Diseases
    Hemophilia
    Duchenne Muscular Dystrophy (DMD)
    Others

Companies Profiled:
    Avexis/Novartis (Zolgensma)
    Sarepta Therapeutics (Elevidys)
    Spark/Roche (Luxturna)
    PTC Therapeutics (Upstaza)
    BioMarin (Roctavian)
    CSL/uniQure (Hemgenix&Glybera)
    Pfizer
    Beijing Innovikang (Pipeline)
    Suzhou NoJieBeig (Pipeline)
    Belief BioMed (Pipeline)

Key Questions Answered
1. How big is the global AAV Gene Therapy Drugs market?
2. What is the demand of the global AAV Gene Therapy Drugs market?
3. What is the year over year growth of the global AAV Gene Therapy Drugs market?
4. What is the total value of the global AAV Gene Therapy Drugs market?
5. Who are the Major Players in the global AAV Gene Therapy Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 AAV Gene Therapy Drugs Introduction
    1.2 World AAV Gene Therapy Drugs Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World AAV Gene Therapy Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World AAV Gene Therapy Drugs Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company AAV Gene Therapy Drugs Revenue (2019-2030)
        1.3.3 China Based Company AAV Gene Therapy Drugs Revenue (2019-2030)
        1.3.4 Europe Based Company AAV Gene Therapy Drugs Revenue (2019-2030)
        1.3.5 Japan Based Company AAV Gene Therapy Drugs Revenue (2019-2030)
        1.3.6 South Korea Based Company AAV Gene Therapy Drugs Revenue (2019-2030)
        1.3.7 ASEAN Based Company AAV Gene Therapy Drugs Revenue (2019-2030)
        1.3.8 India Based Company AAV Gene Therapy Drugs Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 AAV Gene Therapy Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World AAV Gene Therapy Drugs Consumption Value (2019-2030)
    2.2 World AAV Gene Therapy Drugs Consumption Value by Region
        2.2.1 World AAV Gene Therapy Drugs Consumption Value by Region (2019-2024)
        2.2.2 World AAV Gene Therapy Drugs Consumption Value Forecast by Region (2025-2030)
    2.3 United States AAV Gene Therapy Drugs Consumption Value (2019-2030)
    2.4 China AAV Gene Therapy Drugs Consumption Value (2019-2030)
    2.5 Europe AAV Gene Therapy Drugs Consumption Value (2019-2030)
    2.6 Japan AAV Gene Therapy Drugs Consumption Value (2019-2030)
    2.7 South Korea AAV Gene Therapy Drugs Consumption Value (2019-2030)
    2.8 ASEAN AAV Gene Therapy Drugs Consumption Value (2019-2030)
    2.9 India AAV Gene Therapy Drugs Consumption Value (2019-2030)

3 World AAV Gene Therapy Drugs Companies Competitive Analysis
    3.1 World AAV Gene Therapy Drugs Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global AAV Gene Therapy Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for AAV Gene Therapy Drugs in 2023
        3.2.3 Global Concentration Ratios (CR8) for AAV Gene Therapy Drugs in 2023
    3.3 AAV Gene Therapy Drugs Company Evaluation Quadrant
    3.4 AAV Gene Therapy Drugs Market: Overall Company Footprint Analysis
        3.4.1 AAV Gene Therapy Drugs Market: Region Footprint
        3.4.2 AAV Gene Therapy Drugs Market: Company Product Type Footprint
        3.4.3 AAV Gene Therapy Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: AAV Gene Therapy Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: AAV Gene Therapy Drugs Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: AAV Gene Therapy Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: AAV Gene Therapy Drugs Consumption Value Comparison
        4.2.1 United States VS China: AAV Gene Therapy Drugs Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: AAV Gene Therapy Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based AAV Gene Therapy Drugs Companies and Market Share, 2019-2024
        4.3.1 United States Based AAV Gene Therapy Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies AAV Gene Therapy Drugs Revenue, (2019-2024)
    4.4 China Based Companies AAV Gene Therapy Drugs Revenue and Market Share, 2019-2024
        4.4.1 China Based AAV Gene Therapy Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies AAV Gene Therapy Drugs Revenue, (2019-2024)
    4.5 Rest of World Based AAV Gene Therapy Drugs Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based AAV Gene Therapy Drugs Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies AAV Gene Therapy Drugs Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World AAV Gene Therapy Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 scAAV9 Vector
        5.2.2 AVV2 Vector
        5.2.3 AVV5 Vector
        5.2.4 AAVrh74 Vector
    5.3 Market Segment by Type
        5.3.1 World AAV Gene Therapy Drugs Market Size by Type (2019-2024)
        5.3.2 World AAV Gene Therapy Drugs Market Size by Type (2025-2030)
        5.3.3 World AAV Gene Therapy Drugs Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World AAV Gene Therapy Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Spinal Muscular Atrophy (SMA)
        6.2.2 Ophthalmic Diseases
        6.2.3 Hemophilia
        6.2.4 Duchenne Muscular Dystrophy (DMD)
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World AAV Gene Therapy Drugs Market Size by Application (2019-2024)
        6.3.2 World AAV Gene Therapy Drugs Market Size by Application (2025-2030)
        6.3.3 World AAV Gene Therapy Drugs Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Avexis/Novartis (Zolgensma)
        7.1.1 Avexis/Novartis (Zolgensma) Details
        7.1.2 Avexis/Novartis (Zolgensma) Major Business
        7.1.3 Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Product and Services
        7.1.4 Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Avexis/Novartis (Zolgensma) Recent Developments/Updates
        7.1.6 Avexis/Novartis (Zolgensma) Competitive Strengths & Weaknesses
    7.2 Sarepta Therapeutics (Elevidys)
        7.2.1 Sarepta Therapeutics (Elevidys) Details
        7.2.2 Sarepta Therapeutics (Elevidys) Major Business
        7.2.3 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Product and Services
        7.2.4 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Sarepta Therapeutics (Elevidys) Recent Developments/Updates
        7.2.6 Sarepta Therapeutics (Elevidys) Competitive Strengths & Weaknesses
    7.3 Spark/Roche (Luxturna)
        7.3.1 Spark/Roche (Luxturna) Details
        7.3.2 Spark/Roche (Luxturna) Major Business
        7.3.3 Spark/Roche (Luxturna) AAV Gene Therapy Drugs Product and Services
        7.3.4 Spark/Roche (Luxturna) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Spark/Roche (Luxturna) Recent Developments/Updates
        7.3.6 Spark/Roche (Luxturna) Competitive Strengths & Weaknesses
    7.4 PTC Therapeutics (Upstaza)
        7.4.1 PTC Therapeutics (Upstaza) Details
        7.4.2 PTC Therapeutics (Upstaza) Major Business
        7.4.3 PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Product and Services
        7.4.4 PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 PTC Therapeutics (Upstaza) Recent Developments/Updates
        7.4.6 PTC Therapeutics (Upstaza) Competitive Strengths & Weaknesses
    7.5 BioMarin (Roctavian)
        7.5.1 BioMarin (Roctavian) Details
        7.5.2 BioMarin (Roctavian) Major Business
        7.5.3 BioMarin (Roctavian) AAV Gene Therapy Drugs Product and Services
        7.5.4 BioMarin (Roctavian) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 BioMarin (Roctavian) Recent Developments/Updates
        7.5.6 BioMarin (Roctavian) Competitive Strengths & Weaknesses
    7.6 CSL/uniQure (Hemgenix&Glybera)
        7.6.1 CSL/uniQure (Hemgenix&Glybera) Details
        7.6.2 CSL/uniQure (Hemgenix&Glybera) Major Business
        7.6.3 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Product and Services
        7.6.4 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 CSL/uniQure (Hemgenix&Glybera) Recent Developments/Updates
        7.6.6 CSL/uniQure (Hemgenix&Glybera) Competitive Strengths & Weaknesses
    7.7 Pfizer
        7.7.1 Pfizer Details
        7.7.2 Pfizer Major Business
        7.7.3 Pfizer AAV Gene Therapy Drugs Product and Services
        7.7.4 Pfizer AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Pfizer Recent Developments/Updates
        7.7.6 Pfizer Competitive Strengths & Weaknesses
    7.8 Beijing Innovikang (Pipeline)
        7.8.1 Beijing Innovikang (Pipeline) Details
        7.8.2 Beijing Innovikang (Pipeline) Major Business
        7.8.3 Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Product and Services
        7.8.4 Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Beijing Innovikang (Pipeline) Recent Developments/Updates
        7.8.6 Beijing Innovikang (Pipeline) Competitive Strengths & Weaknesses
    7.9 Suzhou NoJieBeig (Pipeline)
        7.9.1 Suzhou NoJieBeig (Pipeline) Details
        7.9.2 Suzhou NoJieBeig (Pipeline) Major Business
        7.9.3 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Product and Services
        7.9.4 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Suzhou NoJieBeig (Pipeline) Recent Developments/Updates
        7.9.6 Suzhou NoJieBeig (Pipeline) Competitive Strengths & Weaknesses
    7.10 Belief BioMed (Pipeline)
        7.10.1 Belief BioMed (Pipeline) Details
        7.10.2 Belief BioMed (Pipeline) Major Business
        7.10.3 Belief BioMed (Pipeline) AAV Gene Therapy Drugs Product and Services
        7.10.4 Belief BioMed (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Belief BioMed (Pipeline) Recent Developments/Updates
        7.10.6 Belief BioMed (Pipeline) Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 AAV Gene Therapy Drugs Industry Chain
    8.2 AAV Gene Therapy Drugs Upstream Analysis
    8.3 AAV Gene Therapy Drugs Midstream Analysis
    8.4 AAV Gene Therapy Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World AAV Gene Therapy Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World AAV Gene Therapy Drugs Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World AAV Gene Therapy Drugs Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World AAV Gene Therapy Drugs Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World AAV Gene Therapy Drugs Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World AAV Gene Therapy Drugs Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World AAV Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World AAV Gene Therapy Drugs Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World AAV Gene Therapy Drugs Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key AAV Gene Therapy Drugs Players in 2023
 Table 12. World AAV Gene Therapy Drugs Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global AAV Gene Therapy Drugs Company Evaluation Quadrant
 Table 14. Head Office of Key AAV Gene Therapy Drugs Players
 Table 15. AAV Gene Therapy Drugs Market: Company Product Type Footprint
 Table 16. AAV Gene Therapy Drugs Market: Company Product Application Footprint
 Table 17. AAV Gene Therapy Drugs Mergers & Acquisitions Activity
 Table 18. United States VS China AAV Gene Therapy Drugs Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China AAV Gene Therapy Drugs Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based AAV Gene Therapy Drugs Companies, Headquarters (States, Country)
 Table 21. United States Based Companies AAV Gene Therapy Drugs Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies AAV Gene Therapy Drugs Revenue Market Share (2019-2024)
 Table 23. China Based AAV Gene Therapy Drugs Companies, Headquarters (Province, Country)
 Table 24. China Based Companies AAV Gene Therapy Drugs Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies AAV Gene Therapy Drugs Revenue Market Share (2019-2024)
 Table 26. Rest of World Based AAV Gene Therapy Drugs Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies AAV Gene Therapy Drugs Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies AAV Gene Therapy Drugs Revenue Market Share (2019-2024)
 Table 29. World AAV Gene Therapy Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World AAV Gene Therapy Drugs Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World AAV Gene Therapy Drugs Market Size by Type (2025-2030) & (USD Million)
 Table 32. World AAV Gene Therapy Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World AAV Gene Therapy Drugs Market Size by Application (2019-2024) & (USD Million)
 Table 34. World AAV Gene Therapy Drugs Market Size by Application (2025-2030) & (USD Million)
 Table 35. Avexis/Novartis (Zolgensma) Basic Information, Manufacturing Base and Competitors
 Table 36. Avexis/Novartis (Zolgensma) Major Business
 Table 37. Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Product and Services
 Table 38. Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Avexis/Novartis (Zolgensma) Recent Developments/Updates
 Table 40. Avexis/Novartis (Zolgensma) Competitive Strengths & Weaknesses
 Table 41. Sarepta Therapeutics (Elevidys) Basic Information, Manufacturing Base and Competitors
 Table 42. Sarepta Therapeutics (Elevidys) Major Business
 Table 43. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Product and Services
 Table 44. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Sarepta Therapeutics (Elevidys) Recent Developments/Updates
 Table 46. Sarepta Therapeutics (Elevidys) Competitive Strengths & Weaknesses
 Table 47. Spark/Roche (Luxturna) Basic Information, Manufacturing Base and Competitors
 Table 48. Spark/Roche (Luxturna) Major Business
 Table 49. Spark/Roche (Luxturna) AAV Gene Therapy Drugs Product and Services
 Table 50. Spark/Roche (Luxturna) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Spark/Roche (Luxturna) Recent Developments/Updates
 Table 52. Spark/Roche (Luxturna) Competitive Strengths & Weaknesses
 Table 53. PTC Therapeutics (Upstaza) Basic Information, Manufacturing Base and Competitors
 Table 54. PTC Therapeutics (Upstaza) Major Business
 Table 55. PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Product and Services
 Table 56. PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. PTC Therapeutics (Upstaza) Recent Developments/Updates
 Table 58. PTC Therapeutics (Upstaza) Competitive Strengths & Weaknesses
 Table 59. BioMarin (Roctavian) Basic Information, Manufacturing Base and Competitors
 Table 60. BioMarin (Roctavian) Major Business
 Table 61. BioMarin (Roctavian) AAV Gene Therapy Drugs Product and Services
 Table 62. BioMarin (Roctavian) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. BioMarin (Roctavian) Recent Developments/Updates
 Table 64. BioMarin (Roctavian) Competitive Strengths & Weaknesses
 Table 65. CSL/uniQure (Hemgenix&Glybera) Basic Information, Manufacturing Base and Competitors
 Table 66. CSL/uniQure (Hemgenix&Glybera) Major Business
 Table 67. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Product and Services
 Table 68. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. CSL/uniQure (Hemgenix&Glybera) Recent Developments/Updates
 Table 70. CSL/uniQure (Hemgenix&Glybera) Competitive Strengths & Weaknesses
 Table 71. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 72. Pfizer Major Business
 Table 73. Pfizer AAV Gene Therapy Drugs Product and Services
 Table 74. Pfizer AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Pfizer Recent Developments/Updates
 Table 76. Pfizer Competitive Strengths & Weaknesses
 Table 77. Beijing Innovikang (Pipeline) Basic Information, Manufacturing Base and Competitors
 Table 78. Beijing Innovikang (Pipeline) Major Business
 Table 79. Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Product and Services
 Table 80. Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Beijing Innovikang (Pipeline) Recent Developments/Updates
 Table 82. Beijing Innovikang (Pipeline) Competitive Strengths & Weaknesses
 Table 83. Suzhou NoJieBeig (Pipeline) Basic Information, Manufacturing Base and Competitors
 Table 84. Suzhou NoJieBeig (Pipeline) Major Business
 Table 85. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Product and Services
 Table 86. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Suzhou NoJieBeig (Pipeline) Recent Developments/Updates
 Table 88. Suzhou NoJieBeig (Pipeline) Competitive Strengths & Weaknesses
 Table 89. Belief BioMed (Pipeline) Basic Information, Manufacturing Base and Competitors
 Table 90. Belief BioMed (Pipeline) Major Business
 Table 91. Belief BioMed (Pipeline) AAV Gene Therapy Drugs Product and Services
 Table 92. Belief BioMed (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Belief BioMed (Pipeline) Recent Developments/Updates
 Table 94. Belief BioMed (Pipeline) Competitive Strengths & Weaknesses
 Table 95. Global Key Players of AAV Gene Therapy Drugs Upstream (Raw Materials)
 Table 96. Global AAV Gene Therapy Drugs Typical Customers


List of Figures
 Figure 1. AAV Gene Therapy Drugs Picture
 Figure 2. World AAV Gene Therapy Drugs Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World AAV Gene Therapy Drugs Total Revenue (2019-2030) & (USD Million)
 Figure 4. World AAV Gene Therapy Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World AAV Gene Therapy Drugs Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company AAV Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company AAV Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company AAV Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company AAV Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company AAV Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company AAV Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company AAV Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 13. AAV Gene Therapy Drugs Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 16. World AAV Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 18. China AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 23. India AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of AAV Gene Therapy Drugs by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for AAV Gene Therapy Drugs Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for AAV Gene Therapy Drugs Markets in 2023
 Figure 27. United States VS China: AAV Gene Therapy Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: AAV Gene Therapy Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World AAV Gene Therapy Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World AAV Gene Therapy Drugs Market Size Market Share by Type in 2023
 Figure 31. scAAV9 Vector
 Figure 32. AVV2 Vector
 Figure 33. AVV5 Vector
 Figure 34. AAVrh74 Vector
 Figure 35. World AAV Gene Therapy Drugs Market Size Market Share by Type (2019-2030)
 Figure 36. World AAV Gene Therapy Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 37. World AAV Gene Therapy Drugs Market Size Market Share by Application in 2023
 Figure 38. Spinal Muscular Atrophy (SMA)
 Figure 39. Ophthalmic Diseases
 Figure 40. Hemophilia
 Figure 41. Duchenne Muscular Dystrophy (DMD)
 Figure 42. Others
 Figure 43. World AAV Gene Therapy Drugs Market Size Market Share by Application (2019-2030)
 Figure 44. AAV Gene Therapy Drugs Industrial Chain
 Figure 45. Methodology
 Figure 46. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Avexis/Novartis (Zolgensma)
Sarepta Therapeutics (Elevidys)
Spark/Roche (Luxturna)
PTC Therapeutics (Upstaza)
BioMarin (Roctavian)
CSL/uniQure (Hemgenix&Glybera)
Pfizer
Beijing Innovikang (Pipeline)
Suzhou NoJieBeig (Pipeline)
Belief BioMed (Pipeline)

Related Reports

Global AAV Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global AAV Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 22 Nov 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global AAV Gene Therapy Drugs market size was valued at US$ 1564 million in 2023 and is forecast to a readjusted size of USD 8306 million by 2030 with a CAGR of 25.7% during review period.

Product Tags

AAV Gene Therapy Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>